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Abstract
Background: Cancer is a major public health concern all over the world. The aim of the current study is to demonstrate changing
trends of cancer incidence from 2006 to 2009 in Tehran (capital city of Iran) and evaluate the effect of living in different regions
according to their median socioeconomic status (SES) on cancer cumulative incidence.
Methods: The incident cases were obtained from the population based cancer register of ministry of health and medicine in Iran; we
examined the annual percent changes (APCs) and overall trends of total cancer incidence across regions in Tehran. The age and sex
standardized incidence rates were computed by the direct method. Poisson regression and negative binominal regression model
were used to assess the existence of trends across 4 consecutive years, as well as the effect of living in each region, literacy rate, and
employment rate across regions on this trend. All the analyses were done by Stata 12.0 software.
Results: The findings of this study showed downward and nonlinear trend during 4 years. The age-standardized incidence rate
(ASR) was higher in men compared to women in this period. ASRs for overall 4 years were 114 and 101 per 10,0000 men and women,
respectively. Average annual percent change based on ASR and regression model for each sex was the same and around -5% and
-6%, respectively. Incidence rate also differed between districts so that north and center districts had higher incidence than south-
ern parts in both sexes. The lowest rate ratio attributed to district 17 and 18 located in south of Tehran and the highest rate ratio
attributed to district 6 for each sex compared to the baseline district 16. Results reported the sharp increase of 59% and 37% in dis-
trict 6 compared to district 16 in men and women, respectively. Better regional social status increased the risk of cancer among
women. Also, the results showed a partially significant interaction with higher decrease in annual trend of cancer rate in socially
more deprived regions.
Conclusions: The results showed downward and nonlinear decreasing trend during 4 years, especially in regions with lower socioe-
conomic status. Incidence rate also differed between districts so that northern regions had higher incidence than southern regions.
Spatio-temporal Analysis of these cancer rates with adjustment for more regional socio-economic characteristics may better explain
the disparities in rate of cancer in different districts across time.
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1. Background
Cancer is a major public health concern all over the
world and the major culprit of one of the 5 causes of death
in all age groups in males and females (1). There were 14.1
million new cases of cancer and 8.2 million deaths caused
by cancer in 2012 globally. The Age standardized rate (ASR)
is a summary measure of the rate or weighted average of
the age-specific rates based on standard population that is
usually world standard population. Age standardized rates
can be compared easily between different countries. Age
standardized incidence rate of cancer per 100,000 popula-
tion is 205.4 and 165, respectively, among men and women
all over the world. Its age standardized mortality rate is
126.3 and 82.9 per 10,0000 population among men and
women, respectively. Incidence rates have more regional
variability than mortality rate. There is also more variabil-
ity among men than women (2).
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in
noncommercial usages, provided the original work is properly cited.
Rohani-Rasaf M et al.
Generally, 57% of new cancer cases happen in less de-
veloped regions (2). For all cancers combined except non-
melanoma skin cancer, men and women in the Asian eth-
nic groups have significantly lower risk of getting cancer
than White ethnic groups (3).
The most common cancers identified globally altered
slightly over the last 40 years (4-8). ASR for all cancers in
Great Britain increased by 23% and 43% in men and women
during 1975 to 2009, but over the past 10 years (2000 -
2011), the ASR increased by 3% and 7% in men and women
(2). Socioeconomic deprivation is one of the important fac-
tors, which affect cancer. ASR is lower in the least deprived
groups than the more deprived groups (9). “Westerniza-
tion” effect is associated with human development index
(HDI) and low HDI countries are likely to have increased
the incidence of breast, prostate, and colorectal cancers.
Based on projections to 2030, if the recent trends in major
cancers continue, the burden of cancer will increase 68%
compared with 2012, and a higher percentage of this in-
crease will happen in low and medium HDI countries and
lower percentage in high and very high HDI countries; Iran
is currently among the high HDI countries (2, 10). Can-
cer is a health concern and the third most common cause
of death in Iran (11). Studies have shown that cancer inci-
dence varies across areas (12, 13) and this variations in can-
cer rates is probably attributed to the environmental risk
factors (14, 15), geographical (16-18), and ethnic (19, 20) vari-
ations rather than genetic differences.
Removing disparities particularly in cancer incidence
is considered as a main health policy. Understanding the
disparity status and its causes and scope help us to remove
it (21).
Surveillance programs for cancer incidence, its distri-
bution across locations, and its time trend are important
for cancer research. Besides, future projection of cancer in-
cidence according to the current trends helps policy mak-
ers to make the right decision on establishing programs
for control and decrease in the burden of this disease.
The aim of the current study is to demonstrate chang-
ing the trends of cancer incidence from 2006 to 2009 in
Tehran (capital city of Iran) and evaluate the effect of living
in different municipality regions of this city (as a proxy for
all contextual factors related to living in that region and as
ecological variables have some effect on getting cancer) on
the rate of cancer after adjustment for mean age, literacy
rate, and employment rate in these regions.
2. Methods
2.1. Study Design
A cross sectional study on the pathologic-based data
was designed. We examined all the cancer cases registered
in the pathology and hospital base cancer registry of Min-
istry of Health during a 4-year period of 2006 to 2009; they
all were residents in Tehran. This registry collects informa-
tion on approximately 80% of cancer cases (22, 23). This ar-
ticle was a secondary data analysis on cancer registry data
and all the personal data of individuals were confidential.
The proposal of the paper was confirmed by Shahid Be-
heshti University of Medical Sciences research committee
and ethical committee.
2.2. Data Sources
Tehran metropolitan area is divided into 22 municipal
districts. Population number, employment, and literacy
rate of each district in strata defined by each sex and 5-
year age groups were obtained from the census data of Iran
Statistics Center in 2005. The population number and lit-
eracy rate of the following years after census 2005 was es-
timated by applying the population growth rate for each
sex-age group strata across all municipality districts and
regions. Employment rate was calculated by dividing the
numbers of employed people by population more than 10
years old (this variable is registered in the census for the
population over 10 years old) and literacy rate was calcu-
lated by dividing the number of literate people by popu-
lation more than 6 years old in each sex age group strata
across regions and municipality districts.
2.3. Statistical Analysis
The age and sex standardized incidence rates and their
95% confidence intervals using the direct method and
World Health Organization (WHO) standard population of
2000 were computed.
The trend of cancer rate during the 4-year period of
2006 to 2009 was estimated in the Tehran and all its 22 dis-
tricts. We also grouped Tehran districts into 4 regions, ac-
cording to their median socioeconomic status (SES), which
were defined previously in a study titled “Measuring so-
cioeconomic disparities in cancer incidence in Tehran,
2008” (12). SES index was calculated based on household
assets, housing characteristics, and education level. Assets
and house features consisted of house ownership, room
per person, area per capita, having bath, kitchen, toilet, car,
phone, cell phone, freezer, computer, and the years of ed-
ucation were also calculated for individuals older than 6
years across all 22 districts of Tehran. Districts 15 to 20 were
categorized in region 1 that located in south of Tehran de-
noting the lowest socioeconomic status (SES), districts 9 to
14 and 21 located in middle of Tehran categorized in the re-
gion 2, districts 4, 7, 8, 22 were classified in region 3 located
and districts 1 to 3 and 5 and 6 were categorized in the re-
gion 4, which were located in north of Tehran with highest
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socioeconomic index. The change of cancer trend in these
regions and their interactions were also assessed.
Poisson regression and negative binominal regression
model were used to assess the significance of incidence
trends across 4 consecutive years from 2006 to 2009, as
well as the effects of living in regions and municipality dis-
trict on incidence rate. The above model was also adjusted
for the literacy and employment rate of each region and
district as contextual factors, which might explain part of
the disparity of incidence rate among regions in each sex-
age group combination. Since literacy and employment
rate were not meaningful in age-group less than 10, this
model was fitted on the population of more than 10 years
old.
Four models with increasing complexity were fitted to
the data. In model zero, the effect of calendar year and age
group on incidence rate I each region were estimated. In
model 1 and 2, municipality districts and literacy rate were
added to the model zero, respectively. In model 3, employ-
ment rate was added to the previous model (Models 1 - 3
for districts are available in the supplementary file). When-
ever the dispersion in the data was more than a true poison
distribution, we changed to a negative binomial regres-
sion model. Considering the difference between cancers
rates in both sexes, all the models were fitted separately in
both sexes. Model selection was according to likelihood ra-
tio test and Akaike’s information criteria (AIC).
Annual percent changes (APCs) for the incidence rates
can be calculated as difference between 2 years divided by
base year incidence rate times 100. For estimating APCs,
we used the following formula; (exp(β) - 1) × 100, where
β is the coefficient of variable year in the model adjusted
for all above-mentioned variables (24, 25). All the analyses




During the 4-year period, 30 827 cancer cases were reg-
istered in Tehran from 2006 to 2009 with male to female
sex ratio of 1.09. The age-standardized incidence rate (ASR)
was higher in men compared with women in this period.
The sex ratio ranged from 1.08 to 1.15. ASRs for 4 years were
114 and 101 per 100,000 men and women in Tehran, respec-
tively. The highest ASR was 123 among men in 2006. Av-
erage annual percent change (AAPC) based on ASR and re-
gression model for each sex was the same and around -5%
and -6%, respectively. Table 1 shows crude, ASR and their
confidence intervals, and APC. Figure 1 depicts ASR cancer
incidence rates in Tehran.
3.2. Models
Over time, the trend of cancer rate decreased nonlin-
early (in a quadratic form) and the model with variable
year with power 2 had less AIC than other transformations
of year variable; hence, we entered an ordinal variable con-
taining power 2 of year in all models.
3.3. Regions with Different Socioeconomic Status
After grouping the districts in 4 socioeconomical dif-
ferent regions, region 4 in the northern area of municipal-
ity with higher socioeconomic position showed 1.31 higher
incidence rate of cancer in comparison with region 1 in
southern area of Tehran with lower socioeconomic status
among both sexes (Table 2). We also checked the interac-
tion of calendar year of investigation and region. The re-
sults showed a partially significant interaction with higher
decrease in annual trend of cancer rate in socially more de-
prived regions.
We also estimated the effect of living in each district on
cancer mortality rate (The detailed results and tables are
presented in the appendix.). District 16 with the least inci-
dence in south center of Tehran (tables in the supplemen-
tary file) and age group 40, which is the changing point,
were considered baseline, and incidence rate ratios were
reported compared to theses base lines.
The total number of observation was 30,827, but the liv-
ing location of 2,441 persons was missing. The results of
model 0, which was fitted on 30,827 records, are presented
in Table 3.
In model 1 that district was entered (appendix 1, 2 in the
supplementary file), the incidence rate (IR) varied accord-
ing to the districts. The lowest rate ratio was attributed to
district 17 and 18 located in the south of Tehran. The high-
est IRR belonged to district 6 for both sexes. The IRR in this
district was 72% and 90% higher compared to district 16
in men and women respectively, but after adjustment for
literacy and employment, the rate decreased to 59% and
37%. It seems that literacy and employment rate are strong
confounders in this model with more impact in women in
comparison to men.
Northern districts of Tehran (district number 1 to 7)
and 2 other ones, district 11 in center and district 20 in
south of Tehran, had higher incidence compared to district
16. Other districts, which were located mostly in south of
Tehran had lower incidence in both sexes.
The IRR significantly increased with increasing age
groups. This pattern was almost similar among both sexes,
but slope of changes was sharper in men compared to
women. According to the model 3, literacy proportion was
positively associated with cancer incidence. The incidence
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Table 1. Trend of Change in Age Standardized Rate (Per 100,000)
Sex Year Crude Incidence Rate (Per 100,000) ASR*(CI 95%) Per 100,000 APC**
Men
2006 99.9 122.9 (119 - 126.7)
2007 103.1 121 (117.3 - 124.7) -1.55
2008 96 108 (104.5 - 111.4) -10.74
2009 98 105.6 (102.3 - 108.9) -2.22
4 years 99 113.9 (112.1 - 115.6) -0.05
Women
2006 93.4 109.2 (105.5 - 112.8)
2007 95.2 104.9 (101.4 - 108.3) -3.94
2008 94.7 99.8 (96.5 - 103) -4.86
2009 91.6 93.6 (90.5 - 96.6) -6.21
4 years 93.7 101.3 (99.7-103) -0.05
Abbreviations: APC, annual percent change which is measured based on the ASR; ASR, age standardized rate.
Figure 1. ASR of Total Cancer Among 4 Socioeconomically Ordered Regions of Tehran During 2006 to 2009
rate ratio for each standard deviation increase in the lit-
eracy proportion was 5% and 9% for men and women, re-
spectively. Employment rate did not impact on the risk of
cancer among men on the contrary; among women, each
1 unit increase in standard deviation of employment pro-
portion was significantly associated with 1.6 times the risk
of cancer (appendix 1, 2 in the supplementary file).
4. Discussion
The findings of the present study showed that total
cancer incidence was 114 and 101 per 100 000 men and
women, respectively in Tehran during 2006 to 2009. Both
APC based on ASR and regression model showed a de-
creasing trend. In this study, both sexes showed decreas-
ing trend, but incidence trends in some cities have in-
creased significantly (26-28); in European countries, inci-
dence trends, in males, are decreasing, while for females,
they go on to ascent (29-31).
According to the global pattern of cancer incidence
and trend study, from 1998 to 2002, the rate of cancers was
decreasing in many western countries, but this rate in less
developed and Eastern European countries was increasing
because of changes in lifestyle pattern (32).
According to the annual report of Tehran pathologic
based cancer registry during 1998 to 2001, which re-
vealed information on cancer incidence for Tehran plus Es-
lamshahr and Shemiranat (with population around 5% of
Tehran), the ASR was 121 and 106 for men and women, re-
spectively. The ASR rates in the current study from 2006
t0 2009 were 114 and 101 for men and women, respectively.
Although in the current study, Eslamshar and shemiranat
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Table 2. The Effect of Living in Regions with Different Socioeconomic Status on Total Cancer Incidence Rate in Tehran During 2006 to 2009 by Negative Binominal Regression
Total Cancer Men Women Both Sexes
IRR (CI95) P Value IRR (CI95) P Value IRR P Value
Year 2 0.99 (0.98 - 0.99) < 0.001 0.99 (0.98 - 0.99) < 0.001 0.99 (0.98 - 0.99) < 0.001
Regions 1.1 (1.07 - 1.13) < 0.001 1.04 (1 - 1.08) 0.05 1.07 (1.05 - 1.09) < 0.001
Age group
10 - 14 0.19 (0.12 - 0.3) < 0.001 0.1 (0.07 - 0.13) < 0.001 0.06 (0.05 - 0.08) < 0.001
15 - 19 0.27 (0.19 - 0.39) 0.03 0.16 (0.13 - 0.2) 0.12 0.11 (0.09 - 0.12) < 0.001
20 - 24 0.31 (0.24 - 0.39) < 0.001 0.13 (0.11 - 0.16) < 0.001 0.14 (0.12 - 0.16) < 0.001
25 - 29 0.4 (0.34 - 0.47) < 0.001 0.17 (0.15 - 0.19) < 0.001 0.24 (0.22 - 0.27) < 0.001
30 - 34 0.49 (0.42- 0.57) < 0.001 0.29 (0.26 - 0.33) 0.03 0.38 (0.34 - 0.42) < 0.001
35 - 39 0.69 (0.6 - 0.79) 0.19 0.54 (0.48 - 0.6) 0.47 0.62 (0.56 - 0.68) < 0.001
40 - 44 1 - 1 - 1 -
45 - 49 1.66 (1.47 - 1.88) 0.26 1.73 (1.57 - 1.9) 0.15 1.55 (1.42 - 1.68) < 0.001
50 - 54 3.26 (2.82 - 3.76) 0.44 2.78 (2.46 -3.14) 0.67 2.33 (2.15 - 2.53) < 0.001
55 - 59 5.61 (4.65 -6.77) < 0.001 4.15 (3.56 - 4.84) < 0.001 3.31 (3.05 - 3.6) < 0.001
60 - 64 9.7 (7.59 - 12.41) 0.39 5.85 (4.9 - 6.99) 0.67 4.85 (4.45 - 5.28) < 0.001
65≤ 19.01 (13.79 - 26.2) 0.77 8.52 (6.88 - 10.55) 0.77 8.54 (7.77 - 9.38) < 0.001
Literacya 1.06 (1 - 1.11) 0.04 1.13 (1.09 - 1.18) < 0.001 1.22 (1.18 - 1.25) < 0.001
Employmenta 1.09 (0.95 - 1.25) 0.23 2.08 (1.68 - 2.57) < 0.001 0.81 (0.79 - 0.83) < 0.001
a The effect is estimated for one standard deviation change in the proportion
Table 3. Model 0 – The Effect of Calendar Time and Age-Group on Total Cancer Incidence Rate in Tehran During 2006 to 2009 by Poisson Regression
Total Cancer Men Women
Incidence Rate Ratio (CI 95%) P Value Incidence Rate Ratio (CI 95%) P Value
Year 2a 0.99 (0.99 - 0.99) < 0.001 0.99 (0.99 - 0.99) < 0.001
Age group
0 0.27 (0.22 - 0.32) < 0.001 0.12 (0.1 - 0.14) < 0.001
5 0.1 (0.07 - 0.13) < 0.001 0.05 (0.03 - 0.06) < 0.001
10 0.15 (0.12 - 0.19) 0.03 0.06 (0.05 - 0.08) 0.12
15 0.22 (0.18 - 0.26) < 0.001 0.11 (0.09 - 0.13) < 0.001
20 0.28 (0.24 - 0.33) < 0.001 0.12 (0.1 - 0.13) < 0.001
25 0.37 (0.33 - 0.43) < 0.001 0.19 (0.17 - 0.21) 0.03
30 0.48 (0.42 - 0.55) 0.19 0.33 (0.3 - 0.37) 0.47
35 0.68 (0.6 - 0.76) 0.26 0.59 (0.54 - 0.64) 0.15
40 1 - 1 -
45 1.66 (1.49 - 1.85) 0.44 1.55 (1.43 - 1.66) 0.67
50 3.12 (2.83 - 3.44) < 0.001 2.09 (1.94 - 2.25) < 0.001
55 5.17 (4.71 - 5.69) 0.39 2.69 (2.5 - 2.89) 0.67
60 8.42 (7.68 - 9.24) 0.77 3.37 (3.13 - 3.63) 0.77
65 14.64 (13.45 - 15.92) < 0.001 3.94 (3.7 - 4.2) < 0.001
a Year power 2 (1 power 2 for 2006 and 4 power 2 for 2009).
cities are not included but even after adjusting the rate
according to the population of this city, comparing the
results shows a decrease in the male total cancer rate in
Tehran (33).
Join point regression analysis of data of New York
state cancer registry, which reported all invasive cancers,
showed an increasing trend of cancer incidence from 1976
to 1992 and decreasing trend from 1992 to 2009 in men.
This study also exhibited an increasing trend of invasive
cancers from 1976 to 1998 and a decreasing trend from 1998
to 2009 among women. AAPC in this study was reported -
0.1 in both sexes from 2000 to 2009 (32-34).
These changes in cancer incidence were also reported
in other studies. Surveillance data for cancer prevention
and control in the United States from 1975 to 2000, which
reported overall cancer incidence rates depicted an in-
creasing trend from the mid-1970s through 1992 and de-
creasing trend from 1992 through 1995, which became sta-
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ble afterwards until 2000 (2).
Overall cancer incidence trend may cover important
trend changes in different cancers. For example, in the
United Kingdom from 1993 to 2003, the rate of prostate,
oral, melanoma increased, but the rate of male lung can-
cer, stomach, and bladder, and cervix cancers decreased.
In this period, colorectal and female lung cancer rate were
relatively stable (3). The analysis of cancer trend based
on population-based cancer registries in 4 selected prefec-
tures in Japan between 1985 and 2007 reflected that over-
all cancer incidence increased with an APC of 0.7%. The in-
cidence rate of prostate cancer increased until 2000 with
an APC of 5.1%, obviously rise from 2000 to 2003 with an
APC of 29.7%, and became stable, thereafter. Liver, colorec-
tal, lung (males), and female breast cancer showed consec-
utively a pattern of upward trend, while Stomach cancer
showed downward trend from 1985 with APCs of -1.7% and
-2.5% for males and females, respectively (35).
In line with New York and United States studies, the
present study showed a decreasing trend of total cancer in-
cidence from 2006 to 2009 in Iran, but this trend is triv-
ial. Incidence rate also differed among districts. The north-
ern and central districts had higher incidence than south-
ern districts. The rate of total cancers across district 6
(in the northern area of Tehran) was 60% and 37% higher
than district 16 (which was located in south of Tehran) be-
tween men and women, respectively. Generally, districts lo-
cated in the region 4 in the northern area of municipality
with higher socioeconomic position showed higher inci-
dence rate of cancer in comparison with districts, which
were located in the region 1 in southern area of Tehran
with lower socioeconomic status. The results also demon-
strated higher decrease in annual trend of cancer rate in
socially more deprived regions. A number of probable fac-
tors contribute to these geographical differences such as
uneven distribution of risk factors, availability of medi-
cal services, socioeconomic status differences, and healthy
lifestyle changes (36, 37).
In economically developed countries, 78% of cancer in-
cident cases occur at age 55 and older compared to 58% in
developing countries; in our study, 51% of cancers occurred
at age 55 and older. The difference is largely due to varia-
tions in age structure of the populations (38).
Incidence rate ratio comparing cancer incidence of dif-
ferent age groups to the baseline age group of 40 to 45
years exhibited a sharp rise in men after the age of 65. This
is probably due to the increasing rate of prostate cancer
in this age group. Such a rise was not observed in elderly
women because of steady distribution of breast cancer (8,
39).
In our study, employment and literacy rate had a pos-
itive impact on the risk of cancer among women. In a
study of cancer incidence among residents in Turin dur-
ing 1985 to 1999, lower education level and low occupation
class were associated with the higher risk of overall can-
cer among men. On the contrary, among women, higher
education level was associated with higher risk (RII = 0.78,
95% CI: 0.72 - 0.85). In this study, occupation was not signif-
icantly associated with the risk of cancer (40). Some stud-
ies also support the association of different socioeconomic
factors with the rate of different cancers or their risk fac-
tors (41). For instance, a study across Iran’s provinces from
2003 to 2009 investigated social disparities in breast can-
cer (BC) and ovarian cancer (OC) incidence rates. In this
study, the incidences of BC and OC were higher across the
provinces with higher social rank based on human devel-
opment index (10, 12, 42, 43). Based on European incidence
rates by deprivation quintile england from 2006 to 2010,
all cancers combined ASR excluding non-melanoma skin
cancer were higher in the most deprived than the least de-
prived groups and this is similar for both sexes. Few can-
cers have more cases in less deprived, for example, female
breast and prostate cancer (39). This association might be
partly explained by higher prevalence of risk factors in this
group (9, 44) or more surveillance among women with
higher social rank (45, 46). These results indicate the ef-
fects of underlying some risk and protective factors on dif-
ferent cancer incidence trend and necessity of analysis for
different cancer types separately.
5. Conclusions
The results showed downward and nonlinear decreas-
ing trend during 4 years, especially in regions with lower
socioeconomic status. Incidence rate also differed be-
tween districts so that northern region had higher inci-
dence than southern region. Spatio-temporal Analysis of
theses cancer rates with adjustment for more district and
regional socioeconomic characteristics may reveal this dis-
parities in rate of cancer in different districts across time. It
should also be mentioned that all associations in this study
are estimated according to group data and individual in-
ference of these associations should be done precautiously
to avoid ecological fallacy.
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